Tidal Investments’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	245,768 +200,005	+437%	+$1.02M	﹤0.01%	1398
2025 Q4	$195K	Sell	45,763 -72,574	-61%	-$276K	﹤0.01%	2011
2025 Q3	$377K	Sell	118,337 -194,513	-62%	-$438K	﹤0.01%	1723
2025 Q2	$710K	Sell	312,850 -40,990	-12%	-$66.1K	﹤0.01%	1190
2025 Q1	$225K	Sell	353,840 -28,689	-7%	-$22.2K	﹤0.01%	1646
2024 Q4	$394K	Buy	382,529 +136,528	+55%	+$147K	﹤0.01%	1494
2024 Q3	$290K	Sell	246,001 -12,000	-5%	-$15.2K	﹤0.01%	1611
2024 Q2	$315K	Sell	258,001 -30,100	-10%	-$59.9K	﹤0.01%	1508
2024 Q1	$631K	Sell	288,101 -18,006	-6%	-$33.2K	0.01%	1092
2023 Q4	$474K	Sell	306,107 -12,004	-4%	-$15.8K	0.01%	964
2023 Q3	$410K	Hold	318,111	–	–	0.01%	934
2023 Q2	$547K	Hold	318,111	–	–	0.02%	774
2023 Q1	$480K	Sell	318,111 -27,794	-8%	-$62.8K	0.02%	780
2022 Q4	$553K	Buy	345,905 +34,590	+11%	+$51.2K	0.02%	635
2022 Q3	$451K	Buy	311,315 +103,543	+50%	+$159K	0.02%	598
2022 Q2	$380K	Buy	+207,772	New	+$398K	0.01%	693